Qiongli Su
Zhuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical characteristics, management, and prognosis of ipilimumab-induced hypophysitis: a retrospective analysis of 76 cases.
Journal: Frontiers in endocrinology
Published: March 11, 2026
LDA-VGHB: identifying potential lncRNA-disease associations with singular value decomposition, variational graph auto-encoder and heterogeneous Newton boosting machine.
Journal: Briefings in bioinformatics
Published: August 05, 2023
4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway.
Journal: Frontiers in molecular biosciences
Published: October 05, 2021
The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism.
Journal: Bioscience reports
Published: July 17, 2019
The role of pyruvate kinase M2 in anticancer therapeutic treatments.
Journal: Oncology letters
Published: January 28, 2019
The role of Clusterin in cancer metastasis.
Journal: Cancer management and research
Published: December 04, 2018
Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Journal: Journal of cellular physiology
Published: April 21, 2018
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Journal: Cancer communications (London, England)
Published: December 07, 2017
Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer.
Journal: Journal of cellular and molecular medicine
Published: September 15, 2017
A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
Journal: Oncotarget
Published: January 20, 2017
Combination of metformin with chemotherapeutic drugs via different molecular mechanisms.
Journal: Cancer treatment reviews
Published: December 09, 2016
Last Updated: 09/26/2026